Remote Follow-Up for pituitary tumors: safe or risky?
NCT ID NCT06297473
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares the safety of routine telephone or video follow-ups versus in-person visits for patients with non-functioning pituitary tumors. Over two years, 812 participants will be randomly assigned to remote or in-person check-ups. The goal is to see if remote follow-up is as safe as in-person care in preventing serious complications like adrenal crisis or severe sodium imbalances.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Telephone or video follow-up (behavioral intervention)
- What this could lead to
- If successful, this could allow patients with non-functioning pituitary tumors to safely have routine follow-ups by phone or video instead of traveling to the clinic.
- What could go wrong
- This is a non-inferiority trial, so it may show that remote follow-up is not as safe as in-person visits. The results may not apply to all patients, especially those with complex needs.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-FUNCTIONAL PITUITARY ADENOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Zealand University Hospital
Køge, Region Sjælland, 4600, Denmark